LI KRUSZKA: Open Payments
NPI 1508338039 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,155 in 23 payments from 7 companies in 2025. Trend: 2023 $1,299 · 2024 $1,301 · 2025 $1,155
Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $647 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $177 |
| Axsome Therapeutics, Inc. | 2 | $145 |
| AstraZeneca Pharmaceuticals LP | 2 | $116 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Amgen Inc. | 1 | $22 |
Products named: Wegovy, JARDIANCE, Auvelity, AIRSUPRA, Ozempic, ZENPEP, MOUNJARO, KRYSTEXXA.
Industry payments across FL — which companies pay providers there.
